Bristol-Myers Squibb
BMY
BMY
2,352 hedge funds and large institutions have $104B invested in Bristol-Myers Squibb in 2020 Q4 according to their latest regulatory filings, with 285 funds opening new positions, 944 increasing their positions, 868 reducing their positions, and 108 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,352
Holders Change
+144
Holders Change %
+6.52%
% of All Funds
41.73%
Holding in Top 10
78
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-16.13%
% of All Funds
1.38%
New
285
Increased
944
Reduced
868
Closed
108
Calls
$1.51B
Puts
$1.38B
Net Calls
+$132M
Net Calls Change
+$259M
Top Buyers
| 1 |
BlackRock
New York
|
+$624M |
| 2 |
JPMorgan Chase & Co
New York
|
+$371M |
| 3 |
KBC Group
Brussels,
Belgium
|
+$325M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$314M |
| 5 |
Morgan Stanley
New York
|
+$239M |
